Short-term effects of dapagliflozin on peak VO2 in heart failure and reduced ejection fraction (DAPA-VO2): a randomized clinical trial
23 May 2022 (16:02 - 16:14)
Organised by:
Slides
About the speaker
Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)
4 More presentations in this session
Professor M. Metra (Milan, IT)
Professor P. Ponikowski (Wroclaw, PL)
Access the full session
The Event
Heart Failure 2022
23 May 2022
16:02 CET
You may be interested in
Congress Session
